BLACKLEDGER Selling Watch: AVGO, DKNG, UEC
BLACKLEDGER's latest selling watch update tracks AVGO, DKNG, UEC, NTLA, RXRX, NFLX from the active public watchlist. This post is built from public-safe status data, in-house public signal labels, and outside public source context. It is designed to help readers understand what is happening around each asset without exposing private research methods.
Selling Watch Data
The dedicated feed category for this update is Selling. The latest public scan timestamp is 2026-09-10T08:00:50.296008+00:00.
- AVGO (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- DKNG (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- UEC (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- NTLA (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- RXRX (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- NFLX (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- BA (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
- SOFI (stock): Bear public bias, Extended, public score 9.0/10, status: Paper trading research.
Educational Context: How To Use This Page
This page is not a trade instruction. It is an educational research brief. Readers can use it to understand company or project background, public market context, public status labels, and relevant outside-source headlines before doing their own due diligence.
AVGO Public Research Bio
Name: Broadcom Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Broadcom Inc. designs, develops, and supplies various semiconductor devices and infrastructure software solutions internationally. The company operates in two segments: Semiconductor Solutions and Infrastructure Software. The company offers networking connectivity, such as custom silicon solutions, ethernet switching & routing, ethernet NIC controllers, physical layer devices, and fiber optic components; wireless device connectivity, including RF semiconductor devices, connectivity solutions, custom touch controllers, and inductive charging ASICS; servers and storage system solutions, such as PCIE switches, SAS & raid products, fibre channel products, and HDD & SSD solutions; broadband solutions, includes set-top box, and broadband access; and industrial. The company also offers a private cloud software portfolio, including the VMware Cloud Foundation, Edge, vSphere foundation, telco cloud platform, private AI, live recovery, applicatio
- Latest public price/reference: $364.4
- Public market capitalization: $1733.57B
- Recent public volume/reference: 24.56M
- One-month public movement: -1.6%
- Sector/category: Technology
Why AVGO Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- OpenAI’s Samsung Pivot: The Reality of Manufacturing Dive[redacted]fication — Forkast News
- Marvell Technology Targets $18B as AI Networking and Optics Fuel Growth — MarketBeat
- Broadcom Is 26% Below Its High. What $10,000 Bought a Decade Ago, and When the Gains Landed. — Motley Fool
- Marvell Or NVIDIA: Which One Costs Less Per Dollar Of Profit? — Trefis
DKNG Public Research Bio
Name: DraftKings Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
DraftKings Inc. operates as a digital sports entertainment and gaming company in the United States and internationally. The company offers online and retail sports betting, daily fantasy sports, digital lottery couriers, prediction markets, and other products, as well as retails sportsbooks. It also provides iGaming, or online casino products, which includes blackjack, roulette, baccarat and slot machines. In addition, the company engages in the design and development of sports betting and casino gaming software for online and retail sportsbooks, and iGaming operators. DraftKings Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.
- Latest public price/reference: $23.66
- Public market capitalization: $11.75B
- Recent public volume/reference: 9.44M
- One-month public movement: -3.63%
- Sector/category: Consumer Cyclical
Why DKNG Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- Are prediction markets encroaching on sports betting's turf? — Yahoo Finance Video
- NFL Kickoff To Spark Record Betting Season As Prediction Markets Boom. AGA Throws A Flag. — Investor's Business Daily
- $35 Billion on the Line: NFL Kickoff Triggers a High-Stakes Prediction Market War — Barrons.com
- Dear DraftKings Stock Fans, Mark Your Calendars for September 9 — Barchart
UEC Public Research Bio
Name: Uranium Energy Corp.. Market class: stock. Public bias: Bear. Public tier: Extended.
Uranium Energy Corp., together with its subsidiaries, engages in exploration, pre-extraction, extraction, and processing of uranium and titanium concentrates properties in the United States, Canada, and the Republic of Paraguay. The company was formerly known as Carlin Gold Inc. and changed its name to Uranium Energy Corp. in January 2005. The company was incorporated in 2003 and is headquartered in Corpus Christi, Texas.
- Latest public price/reference: $11.6
- Public market capitalization: $5.74B
- Recent public volume/reference: 6.52M
- One-month public movement: 28.32%
- Sector/category: Energy
Why UEC Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock? — Motley Fool
- Uranium Energy Rose as Jefferies Started Coverage — GuruFocus.com
- NuScale Advances Key Safety Component Toward SMR Commercialization — Zacks
- NuScale Power Rises 4%, Oklo Climbs 3% as Risk Appetite Returns, Uranium Energy Ticks Up — 24/7 Wall St.
NTLA Public Research Bio
Name: Intellia Therapeutics, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies. The company offers clustered, regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated 9 (Cas9) technology for genome editing. The company provides a modular platform, to advance in vivo and ex vivo therapies for diseases. The company's in vivo product candidates include nexiguran ziclumeran, or NTLA-2001 for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioed[redacted]. Additionally, it offers product candidates for the treatment of immuno-oncology and autoimmune diseases, and multiple in vivo programs to address diseases with significant unmet medical need by delivering gene editing therapeutics to organs outside the liver. The company has license and collaboration agreement with AvenCell Therapeu
- Latest public price/reference: $12.21
- Public market capitalization: $1.71B
- Recent public volume/reference: 4.93M
- One-month public movement: 13.06%
- Sector/category: Healthcare
Why NTLA Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug — Zacks
- 3 Promising Genomics Stocks in the Spotlight in 2026 — Zacks
- Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform — Stocktwits
- Intellia Therapeutics Shares Rise as FDA Grants Priority Review to Lonvo-z — InvestorsHub
RXRX Public Research Bio
Name: Recu[redacted]on Pharmaceuticals, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Recu[redacted]on Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reve[redacted]ble, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and h[redacted]tology oncology. Its preclinical stage product includes REC-7735 for the treatment of
- Latest public price/reference: $3.215
- Public market capitalization: $1.72B
- Recent public volume/reference: 14.09M
- One-month public movement: 8.25%
- Sector/category: Healthcare
Why RXRX Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- 2 Beaten-Down Stocks to Avoid Right Now — Motley Fool
- Why Is Recu[redacted]on Pharmaceuticals (RXRX) Up 8.2% Since Last Earnings Report? — Zacks
- Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook? — Zacks
- The Zacks Analyst Blog Highlights Recu[redacted]on Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci — Zacks
NFLX Public Research Bio
Name: Netflix, Inc.. Market class: stock. Public bias: Bear. Public tier: Extended.
Netflix, Inc. provides entertainment services worldwide. The company offers television (TV) series, documentaries, feature films, games, and live programming across various genres and languages. It also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. Netflix, Inc. was incorporated in 1997 and is headquartered in Los Gatos, California.
- Latest public price/reference: $76.03
- Public market capitalization: $316.58B
- Recent public volume/reference: 22.70M
- One-month public movement: 3.26%
- Sector/category: Communication Services
Why NFLX Is In This Public Update
- BLACKLEDGER public score is in the upgrade-candidate band, so the asset receives expanded public context.
- Current public status: Paper trading research. Public confidence label: High Confidence.
- Current public directional label: bear. This is research context only, not an execution instruction.
Outside Public Headlines / Source Notes
- If a Stock Market Crash Is Coming, [redacted]rt Investors Might Want to Buy This Growth Stock on the Dip — Motley Fool
- Florida Accuses Netflix Of Privacy 'Bait-And-Switch' — MediaPost
- Should You Buy Alphabet Stock For The Chips It Now Sells? — Trefis
- Is Netflix a Good Buy? After 10 Years of Covering NFLX, Here's My Honest Answer. — Motley Fool
What The Public Data Shows
The public feed highlights ticker status, market class, directional bias, score, tier, confidence, company or project profile, public market references, and outside-source headlines. These fields support a deeper view of BLACKLEDGER's public research feed while keeping private methods undisclosed.
Why This Category Matters
The Selling section gives readers a focused path through the market: buying watch content for constructive candidates, selling watch content for defensive movement, investing content for higher-quality public watch names, and market trend notes for broader context.
Research-Only Notice
BLACKLEDGER content is market research only. There is no live execution signal, no recommendation to buy or sell, and no financial advice. Readers should perform their own due diligence and consult licensed professionals before making financial decisions.
Research-only. No execution signal. Not financial advice.